← Leaderboards
Othon Iliopoulos
Dana-Farber Cancer Institute
$11,620,320
Attributed
$12,413,754
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$12,413,754 · 8
By mechanism
R01$8,148,292 · 4
P50$3,887,999 · 3
R29$377,463 · 1
Top collaborators
- Gregory Stephanopoulos5 shared
Most similar at Dana-Farber Cancer Institute
Same institution · by research overlap
- William G Kaelin$28,163,102
- Elizabeth A Maher$5,123,370
- Susan M Bauer-Wu$3,258,546
- William Y Kim$15,134,536
- Mark W Kieran$5,389,245
Others in their field
Top investigators on “Link”
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- David R. Weir · University Of Michigan At Ann Arbor$206,261,870
- Clare E Reimers · Gordon Research Conferences$205,233,456
- Demian A Bailey · Oregon State University$205,233,456
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Greg Ulses · Consortium For Ocean Leadership, Inc$140,113,248
Research focus
LinkMalignant NeoplasmsRenal Cell CarcinomaRenal CarcinomaCell LineSmall MoleculeTumorLaboratoriesSignal TransductionCancer CenterHypoxia Inducible FactorMutationHypoxiaMolecularEvaluationSeriesInhibitor/AntagonistGenesGrowthTranscription FactorClinical TrialsBaseMonitorProteins
Grant awards (35)
Chemical Biology of IRP1-HIF2a Signaling$604,862
R01 · FY2021 · CA · contact PI
Chemical Biology of IRP1-HIF2a Signaling$613,952
R01 · FY2020 · CA · contact PI
Chemical Biology of IRP1-HIF2a Signaling$601,728
R01 · FY2019 · CA · contact PI
Chemical Biology of IRP1-HIF2a Signaling$618,067
R01 · FY2018 · CA · contact PI
Small Molecule HIF2a Inhibitors for Treatment of Renal Cell Carcinoma$248,663
P50 · FY2018 · CA · contact PI
Chemical Biology of IRP1-HIF2a Signaling$642,901
R01 · FY2017 · CA · contact PI
Small Molecule HIF2a Inhibitors for Treatment of Renal Cell Carcinoma$248,969
P50 · FY2017 · CA · contact PI
Hypoxia-induced Metabolic Changes in Cancer$319,362
R01 · FY2016 · CA · contact PI
Hypoxia-induced Metabolic Changes in Cancer$319,362
R01 · FY2015 · CA · contact PI
Hypoxia-induced Metabolic Changes in Cancer$309,781
R01 · FY2014 · CA · contact PI
Tissue Acquisition, Pathology and Clinical Data$478,695
P50 · FY2013 · CA · contact PI
Hypoxia-induced Metabolic Changes in Cancer$300,200
R01 · FY2013 · CA · contact PI
Administration, Evaluation and Planning Core$160,898
P50 · FY2013 · CA · contact PI
Tissue Acquisition, Pathology and Clinical Data$524,585
P50 · FY2012 · CA · contact PI
Identification of Biomarkers for Early Detection of Renal Cell Carcinoma$465,382
R01 · FY2012 · CA · contact PI
Hypoxia-induced Metabolic Changes in Cancer$338,163
R01 · FY2012 · CA · contact PI
Administration, Evaluation and Planning Core$169,897
P50 · FY2012 · CA · contact PI
Tissue Acquisition, Pathology and Clinical Data$499,729
P50 · FY2011 · CA · contact PI
Identification of Biomarkers for Early Detection of Renal Cell Carcinoma$465,383
R01 · FY2011 · CA · contact PI
Administration, Evaluation and Planning Core$161,137
P50 · FY2011 · CA · contact PI
Tissue Acquisition, Pathology and Clinical Data$527,387
P50 · FY2010 · CA · contact PI
Identification of Biomarkers for Early Detection of Renal Cell Carcinoma$479,774
R01 · FY2010 · CA · contact PI
Administration, Evaluation and Planning Core$169,532
P50 · FY2010 · CA · contact PI
Tissue Acquisition, Pathology and Clinical Data$528,673
P50 · FY2009 · CA · contact PI
Identification of Biomarkers for Early Detection of Renal Cell Carcinoma$470,065
R01 · FY2009 · CA · contact PI
Administration, Evaluation and Planning Core$169,834
P50 · FY2009 · CA · contact PI
Identification of Biomarkers for Early Detection of Renal Cell Carcinoma$473,745
R01 · FY2008 · CA · contact PI
Molecular targets of hypoxia in signaling cancer$272,129
R01 · FY2007 · CA · contact PI
Molecular targets of hypoxia in signaling cancer$280,256
R01 · FY2006 · CA · contact PI
Molecular targets of hypoxia in signaling cancer$287,000
R01 · FY2005 · CA
Molecular targets of hypoxia in signaling cancer$286,180
R01 · FY2004 · CA
TUMOR SUPPRESSOR PVHL FUNCTIONAL INTERACTION WITH CUL2$128,795
R29 · FY2002 · CA
TUMOR SUPPRESSOR PVHL FUNCTIONAL INTERACTION WITH CUL2$127,994
R29 · FY2001 · CA
TUMOR SUPPRESSOR PVHL FUNCTIONAL INTERACTION WITH CUL2$110,075
R29 · FY2000 · CA
TUMOR SUPPRESSOR PVHL FUNCTIONAL INTERACTION WITH CUL2$10,599
R29 · FY2000 · CA